Drug Search Results
More Filters [+]

Lindane

Alternative Names: lindane, scabene, kwell, gamene
Latest Update: 2016-07-29
Latest Update Note: Clinical Trial Update

Product Description

Mechanisms of Action: GABA Antagonist

Novel Mechanism: No

Modality: Small Molecule

Route of Administration: N/A

FDA Designation: None *

Approval Status: Approved

Approved Countries: Brazil | Canada | Chile | Colombia | Dominican Republic | Ecuador | Hong Kong | Ireland | Korea | Lebanon | Malaysia | New Zealand | Pakistan | Peru | Philippines | Portugal | Saudi Arabia | South Africa | Taiwan | Tunisia | Turkey | United Arab Emirates | United States | Venezuela

Approved Indications: None

Known Adverse Events: None

Company: None
Company Location:
Company CEO:
Additonal Commercial Interests: None

Clinical Description

Map of Global Clinical Trials for Lindane

Countries in Clinic:

Active Clinical Trial Count:

Highest Development Phases

Trial

Phase

Trial Status

Disease

Primary Completion Date

Probability of Success

Recent News Events

Date

Type

Title